For instance, it has been demonstrated that doxorubicin induced cancer cell death by decreasing HMGCR expression and reducing cholesterol levels, which was mediated by downregulation of HMGCR via inhibition of EGFR/Src pathway [122]. Here, HMGCR is linked to cancer.